Edgestream Partners, L.P. Charles River Laboratories International, Inc. Transaction History

Edgestream Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $3.45 Million - $4.49 Million	16,725 New	16,725 $3.46 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $2.47 Million - $3.5 Million	-9,672 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$351.38 - $448.68 $1.94 Million - $2.48 Million	5,524 Added 133.17%	9,672 $3.64 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $1.55 Million - $1.9 Million	4,148 New	4,148 $1.71 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.